This package consists of two reports and is a 10% savings over buying the reports separately.
These reports analyze two dynamic areas of pharmaceutical research and development; immunotherapy and cancer therapy.

Current Developments in Immunotherapy Markets and Technology
Beyond congenital and acquired immune deficiencies immunotherapy is employed in a number of major disease areas such as hypersensitivity/allergy and cancer. The application in organ transplantation dealing with prevention of allograph rejection and transplantation sickness has long been known. This report from MarketResearch.com examines this market and provides forecasts to 2005 for major immunotherapy products including:

• Corticosteroids
• Cyclosporin and Related Immunosuppresives
• NSAIDS
• Gamma Globulins
• Monoclonal Antibodies
• Cytokines/Lymphokines
• Immunizations and vaccines

In addition, the use of Genetic Manipulation for immunomodulation will be discussed in detail.

The report will present and detail advanced research efforts. Commercial efforts and strategic alliances will be clearly presented for the specific companies profiled in the report.

Advances in Cancer Therapy
As we enter the 21st century, advances in the treatment of cancer will be significant and the patient will benefit in terms of quality of life. It is not unreasonable to anticipate a time when many cancer patients are managed as if they were chronically ill.

These thoughts are being shaped and driven by a variety of forces:

• A new paradigm that would make use of the patient's natural immune and control systems
• The vast array of developing knowledge in the area of cells
• New products under development based on the immune system and cell function or death
• Critical strategic alliances between researched-based pharmaceutical and biotech

This MarketResearch.com study focuses on the five key segments that will impact advanced cancer therapy:

• Immunological and vaccine approaches
• Antiproliferative approaches
• Photodynamic therapy
• Gene therapy approaches
• Cell cycle and apoptosis approaches

The study provides forecast information and examines selected dynamics and cancer statistics for the seven major world markets.

The report provides detailed company profiles which include:

• Current products
• Product pipeline
• Key strategic alliances (large and small)
• Discussions of the core technologies R&D activities

Related Reports:

The Worldwide Market for Cancer Diagnostics, 4th Edition
Apr 1, 2010 - KLI2504623 - $4,200.00

Kalorama Information Library and Annual Subscription
Jan 1, 2010 - KLI1600708 - $55,000.00

The World Market for Biosimilars and the Potential for US Follow-on Biologics
Aug 1, 2009 - KLI2402283 - $3,700.00

World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)
May 1, 2009 - KLI1829596 - $3,500.00

Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition
May 1, 2009 - KLI2091313 - $3,995.00

The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition
May 1, 2009 - KLI2218043 - $3,995.00

Retail Clinics and the In-Store Healthcare Market 2009: Bright Spot in the Current Economy?
Mar 1, 2009 - KLI2041111 - $3,500.00

Women's Health: Worldwide Prescription Drug Markets
Feb 1, 2009 - KLI2071673 - $2,995.00

KTA Pharmaceutical, Device, Diagnostic Subscription
Jan 1, 2009 - KLI2482006 - $45,000.00

Emerging Cancer Vaccines: Market Forecasts, New Developments and Pipeline Analysis, 3rd Edition
Nov 1, 2008 - KLI1646591 - $3,995.00